Intact Investment Management Inc. acquired a new stake in Sangoma Technologies Co. (NASDAQ:SANG – Free Report) during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 286,500 shares of the company’s stock, valued at approximately $1,587,000.
A number of other hedge funds and other institutional investors also recently made changes to their positions in SANG. Hillsdale Investment Management Inc. bought a new position in shares of Sangoma Technologies in the first quarter valued at $765,000. Toronto Dominion Bank grew its stake in shares of Sangoma Technologies by 1.3% in the second quarter. Toronto Dominion Bank now owns 500,353 shares of the company’s stock valued at $2,471,000 after buying an additional 6,243 shares in the last quarter. Acadian Asset Management LLC bought a new position in shares of Sangoma Technologies in the second quarter valued at $188,000. Finally, Unique Wealth LLC bought a new position in shares of Sangoma Technologies in the second quarter valued at $427,000. 39.65% of the stock is currently owned by institutional investors and hedge funds.
Sangoma Technologies Price Performance
NASDAQ:SANG opened at $6.24 on Tuesday. Sangoma Technologies Co. has a 1-year low of $2.18 and a 1-year high of $6.43. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.95 and a quick ratio of 0.70. The firm has a fifty day simple moving average of $5.65 and a 200 day simple moving average of $5.22.
About Sangoma Technologies
Sangoma Technologies Corporation develops, manufactures, distributes, and supports voice and data connectivity components for software-based communication applications worldwide. The company offers Switchvox, a voice over internet protocol phone system; Switchvox Cloud, a unified communications solution, as well as provides cloud communication solutions.
Recommended Stories
- Five stocks we like better than Sangoma Technologies
- Transportation Stocks Investing
- Intel: Is Now the Time to Be Brave?
- What Investors Need to Know to Beat the Market
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- What is MarketRank™? How to Use it
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Want to see what other hedge funds are holding SANG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sangoma Technologies Co. (NASDAQ:SANG – Free Report).
Receive News & Ratings for Sangoma Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sangoma Technologies and related companies with MarketBeat.com's FREE daily email newsletter.